19 Aug 2026
Maternal RSV vaccination cuts infant hospitalisation risk by about 80%
New Australian research suggests maternal RSV vaccination provides strong protection against hospitalisation in young infants, with the greatest benefit seen during the first two months of life.
19 Aug 2026
IV iron treatment rises sharply, but administration costs remain a barrier
Intravenous iron treatment has become far more common among Australian women, but the lack of a specific Medicare Benefits Schedule (MBS) item for administering the treatment can leave some patients facing significant out-of-pocket costs.
18 Aug 2026
Kalbarri community raises funds to restore local GP services
Residents of Kalbarri in Western Australia are raising money to help bring GP services back to their remote community after the town’s only general practice closed in late June.
18 Aug 2026
TGA warns Australians about unapproved melanotan II tanning products
The Therapeutic Goods Administration (TGA) is warning Australians about the risks of melanotan II tanning products promoted online and on social media.
18 Aug 2026
Shoulder pain: why early scans may not help
A new review from Monash University suggests that most people with common shoulder pain can recover with support, advice and time, without needing scans early in their treatment.
14 Aug 2026
Dr Claire Arundell named next ACRRM President
Rural Generalist Dr Claire Arundell has been announced as the next President of the Australian College of Rural and Remote Medicine (ACRRM), with her term set to begin in October.
14 Aug 2026
Rural health leader outlines priorities for Australia’s regional communities
Australia’s National Rural Health Commissioner, Professor Jenny May, has highlighted rural generalism, equity and local healthcare needs as key priorities after two years in the role.
14 Aug 2026
Mounjaro maker still seeking PBS listing in Australia
Eli Lilly says it remains committed to having Mounjaro subsidised through Australia’s Pharmaceutical Benefits Scheme (PBS), despite earlier price negotiations with the Federal Government failing to reach an agreement.
17 Aug 2026
Triptorelin could become more widely available through the PBS
The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended expanding the PBS listing for triptorelin 3.75 mg, potentially improving access for women being treated for several hormone-related conditions.
17 Aug 2026
Measles protection gap grows as travel increases
Around one in 15 Australians were not sufficiently protected against measles in 2019, raising concerns about Australia’s ability to maintain strong population immunity as international travel and global outbreaks increase.